Latanoprost - Glaucoma / ocular hypertension

You are here : Home > Formulary Search > Latanoprost - Glaucoma / ocular hypertension

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Blue

Formulations :

Eye drops
Eye drops (preservative free)
Eye drops (preservative free
unit dose)

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Associated Icons :

Guidelines

SPC

Restrictions / Comments :

Important

Initiation by specialist team before any request to transfer prescribing to primary care.

Preservative free eye drops are available in a 2.5ml BOTTLE. This is the preferred option where PF is required. Noting that unit dose, PF drops are available where patients require this form.

Documentation

Letter to GP

Latanoprost Maximising use of generic prep Letter to GPs - Feb12

Information

NWSCCG: Latanoprost patient information leaflet - Oct 2014

PAD Profile

ChemicalSubstance :

Latanoprost

Indication :

Glaucoma / ocular hypertension

Group Name :

Keywords :

Intra-ocular pressure

Brand Names Include :

Xalatan, Lotacryn, Monoprost

Important Information :

Prescribe generically.

Latest Additions Date From :

Latest Additions Date To :

Guidelines :

Glaucoma / ocular hypertension

Supporting Documents :

Committee Recommendations (3)

02 Oct 24 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

UPON SPECIALIST RECOMMENDATION ONLY

The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.

22 Jul 19 - Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)

Primary care prescribers do not have the necessary equipment or skills to perform ocular pressure readings to make a diagnosis. The APC recomments that this product, when used for treatment of glaucoma, should be considered as BLUE.

Note; the branded product (Xalatan) was considered as BLACK at the PCN in May 2017.

01 Apr 11 - Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)

Pending the imminent patent expiry of Xalatan, generic latanoprost will be the most cost effective prostaglandin analogue in primary and secondary care. Acute trust colleagues are requested to initiate patients on generic latanoprost as the first line prostaglandin analogue. Xalatan prescribing in primary care should be changed to generic.

Other Indications

Below are listed other indications that Latanoprost is used to treat.

No records returned.

Other Drugs

Below are listed other drugs that are used to treat Glaucoma / ocular hypertension.